SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028354
Filing Date
2021-11-15
Accepted
2021-11-15 09:00:38
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1657044
2 ex10-2.htm EX-10.2 7425
3 ex10-3.htm EX-10.3 1895
4 ex31-1.htm EX-31.1 18095
5 ex31-2.htm EX-31.2 17963
6 ex32-1.htm EX-32.1 9073
  Complete submission text file 0001493152-21-028354.txt   7073787

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qlgn-20210930.xsd EX-101.SCH 64148
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qlgn-20210930_cal.xml EX-101.CAL 62946
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qlgn-20210930_def.xml EX-101.DEF 235742
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qlgn-20210930_lab.xml EX-101.LAB 461273
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qlgn-20210930_pre.xml EX-101.PRE 345464
12 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1183028
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 211406709
SIC: 2834 Pharmaceutical Preparations